Dr. Disis on Immunotherapy in Breast Cancer

Mary L. (Nora) Disis, MD
Published: Friday, Apr 14, 2017



Mary L. (Nora) Disis, MD, professor of Medicine, Department of Medicine, University of Washington School of Medicine, discusses immunotherapy for patients with breast cancer.

Immunotherapy is now being tested in breast cancer to determine how it can work more efficiently since it doesn’t seem to be as effective as it is in other cancers, explains Disis.

For the majority of patients with breast cancer, investigators must determine a way to start the correct immune response in order to have an impact on the tumor, states Disis.
 


Mary L. (Nora) Disis, MD, professor of Medicine, Department of Medicine, University of Washington School of Medicine, discusses immunotherapy for patients with breast cancer.

Immunotherapy is now being tested in breast cancer to determine how it can work more efficiently since it doesn’t seem to be as effective as it is in other cancers, explains Disis.

For the majority of patients with breast cancer, investigators must determine a way to start the correct immune response in order to have an impact on the tumor, states Disis.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x